Pharmacokinetics (PK) and pharmacodynamics (PD) of a novel carcinoembryonic antigen (CEA) T-cell bispecific antibody (CEA-CD3 TCB) for the treatment of CEA-positive solid tumors

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 28; p. v28
Main Authors Melero, I., Segal, N.H., Saro, J., Ros, W., Martinez-Garcia, M., Argiles, G., Moreno, V., Ponce, S., Marabelle, A., Cleary, J.M., Hurwitz, H.I., Eder, J.P., Jamois, C., Andersson, E., Bouseida, S., Sandoval, F., Bacac, M., Nayak, T., Karanikas, V., Calvo, E.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.09.2017
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdx363.020